Safety of RSV Preventive Monoclonal Antibody

NCT07158814 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

524

Enrollment

OTHER

Sponsor class

Conditions

Fever
Adverse Event Following Immunisation

Interventions

DRUG: Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]